This document provides an overview and agenda for a session on the Sustainable Procurement Index for Health (SPIH) project. It introduces the moderator and speakers for the session. The session will include an overview of the SPIH concepts, a discussion of the piloting phase where the SPIH was tested, and feedback from the piloting phase. It will conclude with a question and answer period. The objectives of the piloting phase are outlined as understanding how easy or challenging the SPIH is for suppliers to complete and buyers to review, and gathering feedback on the SPIH structure, criteria, and implementation. An overview of the piloting process and the types of feedback requested from participants is also provided.
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Merck Life Sciences
As single-use technologies continue to expand in pharmaceutical manufacturing processes, the risk assessment for extractables and leachables becomes increasingly complex. Join this webinar to obtain guidance on how to perform risk evaluation on a process with multiple single-use components.
A Single-Use System (SUS) is typically designed for a specific process step. In many cases, single-use components are chosen based on their functionality. The challenge arises when there are multiple processing steps-- as the different applications and product matrices are evaluated, the complexity of the risk assessment increases. Complexity includes component evaluation, process conditions, and model solvents streams which ultimately relates to the patient safety risk.
This webinar will evaluate the different single-use components with respect to compatibility and extractables and leachables. A case study will be used to demonstrate the complexity and potential concerns when performing a risk evaluation on the manufacturing process.
In this webinar, you will learn:
- Risk assessment of extractables
- Single-use component evaluation
- Complexity when evaluating multiple assemblies
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Merck Life Sciences
As single-use technologies continue to expand in pharmaceutical manufacturing processes, the risk assessment for extractables and leachables becomes increasingly complex. Join this webinar to obtain guidance on how to perform risk evaluation on a process with multiple single-use components.
A Single-Use System (SUS) is typically designed for a specific process step. In many cases, single-use components are chosen based on their functionality. The challenge arises when there are multiple processing steps-- as the different applications and product matrices are evaluated, the complexity of the risk assessment increases. Complexity includes component evaluation, process conditions, and model solvents streams which ultimately relates to the patient safety risk.
This webinar will evaluate the different single-use components with respect to compatibility and extractables and leachables. A case study will be used to demonstrate the complexity and potential concerns when performing a risk evaluation on the manufacturing process.
In this webinar, you will learn:
- Risk assessment of extractables
- Single-use component evaluation
- Complexity when evaluating multiple assemblies
Standardising Management Systems for Educational Organizations – implications...Anthony Fisher Camilleri
The presentation contains an overview of the upcoming ISO 21001 standard, which will be published in early 2018 as a Management System Standard for Educational Organizations. It shows how ISO 21001 overcomes some of the chief criticisms and limitations of applying ISO 9001 to the field of education, and discusses the principles on which the standard is based. Additionally, it briefly presents the structure of the standard, and discusses how it may be used in conjunction with the Standards and Guidelines for Quality Assurance in the EHEA to fit within an international framework of standards applicable to education.
A proper technology transfer (TT) is both essential and important to drug discovery and development for new medicinal products. It is also required to upgrade drug quality planned during research development and to final product during manufacturing as well as to guarantee that stable quality is transferred
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...Merck Life Sciences
What are the major drivers for the new Annex 1? Join us to know more about implications for Filters & Single Use.
In this webinar, you will learn:
• Closed Processing and Single Use Technology implementation
• Points to consider using Single Use Technology
• Sterile Filtration
The Annex 1 “Manufacture of sterile medicinal products” of the EU GMP Guide is currently being revised. A first draft of the revised version was published in 2017 and released for public comment. The second draft as of February 2020 was open for targeted consultation via stakeholder from selected industry organisations. The current Annex 1 draft emphasises Contamination Control Strategy (CCS) multiple times and as a key consideration.
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...MilliporeSigma
Register for the interactive, on-demand webinar now: https://bit.ly/USP665
Single-use plastic systems are being utilized more frequently especially for COVID-19 vaccine manufacturing. However, there are issues regarding standardization of quality information that limits implementation efficiencies. One of the challenges is the evaluation of leachables derived from a variety of different plastic components in a timely manner.
Since the USP <665> highlights a risk assessment approach with no typical pass/fail limit, approaches to decision-making based on the extractables data package will be reviewed. In addition, we will highlight legacy testing requirements which may not be necessary once USP <665> is implemented.
In this webinar, we will discuss:
- Regulatory expectations of extractables and leachables assessment today and tomorrow
- The right criteria that need to be assessed to select the type and quality of plastic materials for use in biopharmaceutical manufacturing
Sustainable Procurement Index for Health (SPIH) ClinicUN SPHS
Delivered by Arup at the Global Forum 2020 Sustainable Procurement Index for Health Clinic session.
Presenters:
Dr. Kristian Steele, Associate, Arup
Ms. Anna Tuddenham, Consultant, Arup
Mr. Terry Ellis, Senior Consultant, Arup
Mr. Callum Newman, Associate Director and Group Leader for International Development, Arup
Standardising Management Systems for Educational Organizations – implications...Anthony Fisher Camilleri
The presentation contains an overview of the upcoming ISO 21001 standard, which will be published in early 2018 as a Management System Standard for Educational Organizations. It shows how ISO 21001 overcomes some of the chief criticisms and limitations of applying ISO 9001 to the field of education, and discusses the principles on which the standard is based. Additionally, it briefly presents the structure of the standard, and discusses how it may be used in conjunction with the Standards and Guidelines for Quality Assurance in the EHEA to fit within an international framework of standards applicable to education.
A proper technology transfer (TT) is both essential and important to drug discovery and development for new medicinal products. It is also required to upgrade drug quality planned during research development and to final product during manufacturing as well as to guarantee that stable quality is transferred
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...Merck Life Sciences
What are the major drivers for the new Annex 1? Join us to know more about implications for Filters & Single Use.
In this webinar, you will learn:
• Closed Processing and Single Use Technology implementation
• Points to consider using Single Use Technology
• Sterile Filtration
The Annex 1 “Manufacture of sterile medicinal products” of the EU GMP Guide is currently being revised. A first draft of the revised version was published in 2017 and released for public comment. The second draft as of February 2020 was open for targeted consultation via stakeholder from selected industry organisations. The current Annex 1 draft emphasises Contamination Control Strategy (CCS) multiple times and as a key consideration.
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...MilliporeSigma
Register for the interactive, on-demand webinar now: https://bit.ly/USP665
Single-use plastic systems are being utilized more frequently especially for COVID-19 vaccine manufacturing. However, there are issues regarding standardization of quality information that limits implementation efficiencies. One of the challenges is the evaluation of leachables derived from a variety of different plastic components in a timely manner.
Since the USP <665> highlights a risk assessment approach with no typical pass/fail limit, approaches to decision-making based on the extractables data package will be reviewed. In addition, we will highlight legacy testing requirements which may not be necessary once USP <665> is implemented.
In this webinar, we will discuss:
- Regulatory expectations of extractables and leachables assessment today and tomorrow
- The right criteria that need to be assessed to select the type and quality of plastic materials for use in biopharmaceutical manufacturing
Sustainable Procurement Index for Health (SPIH) ClinicUN SPHS
Delivered by Arup at the Global Forum 2020 Sustainable Procurement Index for Health Clinic session.
Presenters:
Dr. Kristian Steele, Associate, Arup
Ms. Anna Tuddenham, Consultant, Arup
Mr. Terry Ellis, Senior Consultant, Arup
Mr. Callum Newman, Associate Director and Group Leader for International Development, Arup
Applying lean thinking in the food supply chain presentationFayssal AL-KILANI
This Presentation shares the improvement in the manufacturing process by the application of lean thinking that was established by Toyota Production Team and gives a real life example of its application and advantages.
Change creates miracles.
Based on his Masters thesis on the differences between ISO 20121 standards and the AOEX/ASTM standards, Andrew Walker presents a full explanation of how these two standards can work together.
The OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas is being used as the basis and benchmark by many industry initiatives. To gauge the alignment, coherence and credibility of these initiatives, the OECD is carrying out an assessment of the alignment of industry programmes’ standards and implementation efforts with the OECD Due Diligence Guidance. This presentation by Hannah Koep-Andrieu of the OECD and Andrew Britton of Kumi Consulting provides an overview of the project.
To find out more, visit https://mneguidelines.oecd.org/industry-initiatives-alignment-assessment.htm
With unprecedented change on the horizon, healthcare organizations are looking to redefine their workflows to focus on quality and efficiency.
Through utilizing SIMUL8 and Lean Six Sigma principles, ECG Management Consultants, Inc. has been able to help clinics and health systems to deliver on the new value proposition in the post-reform era.
The vital interconnections between health, oceans and climate changeUN SPHS
Dr. Richard Hixson (Consultant in Clinical Care Medicine and Co-Founder of Healthcare Ocean) at the 5h Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
Resilient Circular Economy Medical Textile SolutionsUN SPHS
Dr. Tom Dawson
(Founder, Revolution-ZERO and Visiting Research Fellow in Healthcare Circular Economics, University of Exeter) at the 5th Saving Lives Sustainably Global Forum 2022 on 24 November 2022.
Clara Inés Meneses Sandoval (Environmental Management Coordinator, Fundación Club Noel, Colombia) at the 5h Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
Pablo Tobón Uribe Hospital Strategy in the reuse of personal protection eleme...UN SPHS
Ana Zoraida Gomez Diaz (Director, Department of General Services and Environmental Management Hospital Pablo Tobón Uribe, Colombia) at the 5h Saving Lives Sustainably Global Forum 2022 on 24 November 2022.
Resilient Circular Economy Medical Textile SolutionsUN SPHS
Dr. Tom Dawson (Founder, Revolution-ZERO and Visiting Research Fellow in Healthcare Circular Economics, University of Exeter) at the 5th Saving Lives Sustainably Global Forum 2022 on 24 November 2022.
Global Fund Emergency Response for BangladeshUN SPHS
Lahiru Perera (Project Manager, UNOPS) and Ekramul Haque (Deputy Program Manager, National Malaria Elimination & Aedes Transmitted Diseases Control Program, PM, BAN-MAL & Dengue; CDC, DGHS) at the 5th Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
Vaccine supply chain: challenges and opportunitiesUN SPHS
Dr. Asel Sartbaeva
(Reader in Chemistry Department of Chemistry, University of Bath) at the 5th Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
Reducing wasted medical equipment donated by iNGOsUN SPHS
Rodrigo Acosta, Zermeno Biomedical Specialist, International Committee of the Red Cross (ICRC), at the 5th Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
Understanding and addressing the effects of the pandemic on health care waste...UN SPHS
Paeng Lopez, Plastics in Health Care Project Coordinator, Health Care Without Harm Asia, at the 5th Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
Building sustainability into the NHS Supply ChainUN SPHS
By Alexandra Hammond, Head of Sustainable Procurement and Supply, NHS England at the 5th Saving Lives Sustainably Global Forum 2022 on 23 November 2022.
The Global Fund- SPHS Engagement: Responsible Procurement FrameworkUN SPHS
The Global Fund and SPHS will solicit comments and advice on the project, and will collect any relevant experiences that the SPHS members can share from efforts to implement responsible/sustainable procurement practices. Deloitte will also prepare some questions to help focus the discussions.
The recording of the webinar is available here: https://drive.google.com/file/d/1BIYLDyOMVfbcsIzOB-5hfY7FBbI3ZLzh/view
Delivered by Eng. Nizar Al-Hariri, President, National Industrial Development Center, Saudi Arabia at the Global Forum 2020 Innovators from the Field session.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Couples presenting to the infertility clinic- Do they really have infertility...
Sustainable Procurement Index for Health (SPIH) Virtual Session
1.
2. Moderator
and Speakers
• Dr. Rosemary Kumwenda, Team Leader, HIV,
Health and Development, UNDP Eastern Europe
and Central Asia and SPHS Coordinator
• Dr. Kristian Steele, Associate, Arup
• Callum Newman, Associate Director and Group
Leader for International Development, Arup
• Anna Tuddenham, Consultant, Arup
• Terry Ellis, Associate, Arup
Dr Kristian Steele
Kristian.Steele
@arup.com
Anna Tuddenham
Anna.Tuddenham
@arup.com
Terry Ellis
Terry.Ellis
@arup.com
Callum Newman
Callum.Newman
@arup.com
Dr Rosemary
Kumwenda
Rosemary.Kumwenda
@undp.org
3. WHYA
SUSTAINABLE
HEALTHSECTOR?
• The health sector, whose mandate is to
prevent and cure disease, makes a major
contribution to the global climate crisis.
In fact, if the global health sector were a
country, it would be the fifth-largest
greenhouse gas emitter on the planet.
(Health Care Climate Footprint Report)
• The health sector purchases a broad
array of products.The production,
packaging, transportation, use and
disposal of these products has a
significant impact on the health of
people and the environment.
4. Established in 2012, SPHS brings together seven United Nations agencies and three global
health financing institutions, committed to introducing sustainable procurement in the global
health sector and beyond.
The SPHS annual cumulative purchasing power is between 3 to US$5 billion, which
represents a sizable portion of the global pharmaceutical and other health products markets.
The common principles of procurement that are important in the UN procurement system are:
1. Best value for money
2. Fairness, integrity and transparency
3. Effective international competition, and
4. The interests of the United Nations
5. Sustainable Health in Procurement Project (SHiPP)
Project Duration
• Four years, 2018-2021
Programme Objective
• Strengthen sustainable procurement
in the UN system and in strategic
countries to leverage purchasing
power and drive policy and market
demand for sustainable
manufacturing and waste
management in the health sector
Project Location
• Global and in 10 selected project
countries (EECA: Moldova and
Ukraine, Africa: South Africa,
Tanzania and Zambia, Asia: China,
India,Viet Nam, Latin America:
Argentina, Brazil)
Development Objective
• Promote sustainability in the health
sector supply chain to improve
human health and reduce
greenhouse gases, resource
depletion, and chemical pollution
6.
7. Agenda
• Project scope and SPIH concepts 15 mins
• Overview of piloting phase 15 mins
• Feedback from the piloting phase 10 mins
• Q&A 20 mins
This session is being recorded.
Please post your questions in the chat and we will answer
these in the second half of the session.
9. 1.1 Introduction to the Project
This project is working to create the Sustainable Procurement Index for
Health (SPIH). This will:
• Be a globally established, recognised and adaptable measurement tool
for policy makers, manufacturers, suppliers, procurers, and healthcare
facilities end users
• Provide an incentive for entities to improve their environmental and
social sustainability record
• Provide consistency and certainty to the supply chain
• Cover key sustainability themes which are global imperatives
10. 1.2 Project ambition
• To accelerate sustainable procurement in the health sector, by:
• Supporting the decision making of buyers, and providing certainty to
suppliers
• Provide a robust and transparent method, that clearly communicates
expectations for supply chain performance
• Being proportionate and relevant, respecting the materiality and
capability in the supply chain
• Not just focus on risk, but provide clear pathways for stakeholders to
improve their performance
11. 1.3 SHiPP countries
• A four year global project supported by Sida
• UNDP and Health Care Without are developing and piloting a set of
sustainable health procurement practices and policies
• The SPIH development fall under this programme
• Lower and middle income country focus: India, China, Brazil, Argentina,
Moldova, South Africa, Ukraine, Tanzania, Viet Nam, Zambia
12. 1.4 Project plan
We have completed the piloting phase, which determined the structure of
SPIH and its key principles, and developed a first version. We have just
concluded the piloting phase and are now developing the training
materials and user guidance.
Definition
2020H1
Development
2020H2
Piloting
Early 2021
Training
Summer 2021
13. 1.5 Key stakeholder groups
• Buyers
• Suppliers
• Non-government organisations
• Regulatory agencies
• Research bodies
• Other standards bodies
• Expert Panel
14. 1.6 How we engaged
• Survey issued to the Expert Group – good response rate, with some
follow up interviews
• Ongoing interviews with informants with particular emphasis on
suppliers
• Survey also launched to wider base of suppliers
• Extensive literature review and best practice analysis (including from
other sectors)
17. 2.1 Where in procurement?
• The SPIH focuses on a use case during a specific
procurement activity (a buying event), rather than being a
market monitoring tool or supplier/contract performance
tool.
• Buyer led solution will send a stronger signal for now; a
supplier led solution could appear voluntary.
• It aims to support ‘shaping the market’ by leveraging
procurement events with long term potential to transition to
a market based/labelling scheme type solution
18. 2.2 Organisation or product?
• Stakeholder engagement highlighted that there was interest for the
SPIH to consider both organisational aspects of a supplier, and
product-specific aspects.
• A hybrid approach was developed, which tests both
• Arranged around a performance hierarchy, meaning that the SPIH
has:
• Organisational emphasis for ‘baseline’ performance
• Product focus for leading performance
• An example of this concept is presented here for the GHG topic area:
More product focus
More organisation focus
19. 2.3 Key theme areas
• The SPIH looks at four key themes which represent key
global sustainability challenges.
• Within each theme, there are a series of sub-themes –
these range from organisational aspects (governance)
through to product specific considerations (such as use
of restricted substances in a product).
• The four themes and the sub-themes within are:
GHG emissions
• Governance
• Measurement
• Target setting
• Supply chain
issues
Resource depletion
• Governance
• Manufacturing
• Supply chain
issues
Chemicals and
toxicity
• Management
• Restricted
substances
• Disclosure
Human and labour
rights
• Policy and
governance
• Audits
• Equality and
gender issues
21. 2.5 Levels concept and scoring
• The scoring system is based on a
pass/fail principle.
• Each module has a pass threshold of
50%.
• All the modules within a level must
be passed to attain the SPIH level.
• Some modules will be product- or
situation-specific therefore would not
be counted.
• The criteria and scoring approach will
be transparent.
22. 2.6 Criteria development
Theme Question Weighting Criteria / response Score
Scope
Do you measure your
Scope 1 & 2 GHG
footprint?
50%
No 0
Yes, following a recognised
methodology [from list]
20
Yes, following another
methodology
10
Reporting
Do you report your
GHG footprint?
50%
No 0
The results are published
internally
10
They are provided on request 10
Yes, they are published on our
website
30
23. 2.6 Criteria development
SPIH level Question Weight Criteria/response Score
Recycled
content of
product
Have you calculated the
recycled content of the
product?
17%
No 0
Yes, each product has <49%
post-consumer recycled
content
15
Yes, each product has >50%
post-consumer recycled
content
30
Waste and
circular
economy
Are major components of
the product recyclable?
8%
No 0
Yes 20
Waste and
circular
economy
Does the manufacturer
operate a take-back
programme?
8%
No 0
Yes 20
Energy use in
manufacturing
Have you calculated the %
use of renewable energy in
final manufacturing stage?
8%
No 0
Yes, each product has <49
renewable energy used in final
manufacturing stage
10
Yes, each product has >50%
renewable energy used in final
manufacturing stage
20
Energy use in
manufacturing
Are your procedures in line
with ISO5001 or similar
energy management
approach?
8%
No 0
Yes, in line with ISO5001 20
Yes, in line with another
energy management approach
10
Water use in
manufacturing
Have you quantified water
use at final manufacturing
stage?
6%
No 0
Yes 20
24. 2.7 Performance banding
over time
• We received many comments on using the
index to shape the market and it is one of
the key drivers for the Index
• Providing clear signals on expectations
and requirements of suppliers is key
• We are considering a potential model
whereby the ‘baseline’ requirements or
scoring systems become progressively
more challenging over time.
Example: For a given criteria, what is considered
‘Level 1’ performance in 2021 would become
‘baseline’ performance in 2023. A ‘Level 4’
requirement in 2021 would become a ‘Level 1’
requirement in 2030 etc.. This provides a clear
signal to the market on the expectations of the
buyer
25. 2.8 The Tool
We have provided an Excel-based Tool to support the
piloting phase.
26. 2.8 The Tool
The Tool has five worksheets
• SPIH scoring worksheet
• Four theme worksheets
Module
results
Theme
worksheets
Level
achieved
27. 2.8 The Tool
• Within each theme worksheet,
the supplier would complete
the light green shaded cells.
• Each module is presented in
turn.
• Each question has the relevant
weighting presented.
• Depending on the response, the
required evidence will be
presented.
Module
information
Question
weighting
Response
area
30. 3.1 Piloting objectives
• Users’ understanding of the SPIH structure and its scoring
methodology;
• Supplier’s perspective – how easy or challenging is it to
address the questions in the SPIH?;
• Buyer’s perspective – how easy or challenging is it to review
the submission by the supplier?; and
• Content – do the questions make sense? Is the scoring fair
and balanced? Are the questions in the correct levels?.
31. 3.2 Organisations
• We paired buyers and suppliers together to work
through the pilot
• Geography, in particular reflecting SHiPP countries;
• Size of organisation, reflecting both large and small
companies; and
• Also included one supplier working with two buyers,
and a wholesaler.
32. 3.3 Products
• A mix of product supply, covering
a range of potential healthcare
commodities including
pharmaceuticals
Product selected
Antiretroviral drug: Tenofovir DF 300mg +
Lamivudine 300mg + Dolutegravir 50 mg; fixed
dose combination (TLD)
Dolutegravir Disp tabs 10 mg
Enzyme: Dornase alfa
Medical face masks
Syringes
Antiseptic disinfectant: Aurorub
Disposable diaper
Enhle Laundry Disinfectant industrial laundry
detergents
33. 3.4 Piloting process
The process for the piloting exercise was as follows:
Ad hoc support from Arup available
Arup to update the SPIH criteria
34. 3.5 Feedback requested
• Structure of SPIH – the general structure
and organisation of the criteria, modules
and levels within the SPIH, and ability to
understand;
• Content of the criteria – including specific
criteria within any module, the number of
criteria, the scoring and weightings
applied;
• Buyer/supplier specific questions –
relevance of modules, adequate guidance,
barriers to implementation;
• Concerns regarding deployment or
requirements in procurement; and
• Other observations
35. 3.6 General feedback - positives
• They understood the general approach of the SPIH,
its structure and scoring mechanisms;
• They understood the questions within each theme
(although some specific feedback on content was
received, discussed further below);
• They welcomed the consistent approach that the
SPIH can potentially bring to sustainability
considerations in procurement.
36. 3.7 General feedback - constructive
• Detail on technical terms: Some participants asked for
further detail or clarification on certain questions and
themes to support them in responding or reviewing
responses
• Confidentiality: Some participants felt that disclosing some
of the information required to support their answers might
conflict with intellectual property or commercial interests.
This was particularly a concern for pharmaceutical products.
• Use of SPIH by wholesalers: It is not clear how a wholesaler
might use the SPIH and it could be challenging to engage
with multiple product manufacturers.
• Different versions of the SPIH: Some participants identified
situations in which it might be more useful to split the SPIH,
e.g. into separate sustainability themes, or focusing only on
the organisational or product elements.
We’ll be
providing more
information and
support to users
in the User
Guide
38. 4. Next steps
• In the next phase of work, we will be producing
user guidance to help with the application of the
SPIH;
• We expect the SPIH Tools and User Guidance will be
released in late September.
39. 5. Q&A
• Please type your questions in the chat.
Dr Kristian
Steele
Anna
Tuddenham
Terry Ellis
Callum
Newman
Dr Rosemary
Kumwenda
Good morning, good afternoon and good evening everyone. Thank you very much for joining us today at the Sustainable Procurement Index for Health Virtual Session.
I would like to begin with introducing the speakers and moderator. My name is Dr. Rosemary Kumwenda. I am the Team Leader of the HIV, Health and Development Team of the UNDP Eastern Europe and Central Asia and UN Interagency on Sustainable Procurement in the Health Sector Coordinator.
I am joined today by the moderator of the session, Dr. Kristian Steele, Associate at Arup, Mr. Callum Newman the Associate Director and Group Leader for International Development at Arup, Ms. Anna Tuddenham a Consultant at Arup and lastly, Mr. Terry Ellis a Senior Consultant at Arup.
Let me open this vital session by explaining why a sustainable health sector is a must to achieve the Sustainable Development Goals.
Sustainability is crucial to tackle the world’s biggest problems that we are facing today, because human and environmental well-being hinges on social, economical and environmental sustainability and development.
And sustainability must be at the heart of every sector.
However, as the health sector is one of the largest contributors to the global emissions and climate change, health care sustainability is crucial to achieve the 2030 Agenda for Sustainable Development.
The health sector, whose mandate is to prevent and cure disease, makes a major contribution to the global climate crisis. In fact, if the global health sector were a country, it would be the fifth-largest greenhouse gas emitter on the planet.
The global health sector releases greenhouse gases while delivering care and procuring products and technologies from a carbon-intensive supply chain. Health care contributes to carbon emissions through energy consumption, transport, and products manufactured, used, and disposed of.
To tackle this set of issues, in 2012, the UN interagency Task Team on Sustainable Procurement in the Health Sector, widely known as SPHS, was established. The SPHS brings together 7 UN agencies (UNDP, UNICEF, UN Environment Programme, UNFPA, UNHCR, World Health Organization, UNOPS) and 3 global health financing institutions (Unitaid, The Global Fund and Gavi) to strengthen sustainability in the health sector and beyond.
The aim for establishing the SPHS was to coordinate the introduction of sustainable procurement in the health sector among members and to leverage the standard-setting and joint procurement volumes of member agencies to influence the global health sector and beyond.
The UN, through the SPHS, is supporting the development and implementation of sustainable and ethical procurement policies that positively impact the global health care supply chain to achieve net-zero carbon emissions by 2050.
Inspired by a UNDP-Health Care Without Harm pilot funded by the Skoll and UN Foundations in 2015, the Sustainable Health in Procurement Project, SHiPP, set sail as a four-year global project powered by support from the Swedish International Development Cooperation Agency.
The project addresses the intersection between health, human rights and the environment in developing countries. It promotes procurement practices that consider environmental and social impacts, as well as cost-efficiency and affordability when defining how processes can be sustainable and mainstreams gender and human rights including anti-corruption, transparency and accountability.
The project also aims to aggregate demand for sustainable manufacturing and waste management in a critical number of project countries and to slowly but surely move the supply chain towards greater sustainability.
The outcome would be a corresponding positive impact on the environment and on the health of patients, hospital staff, workers at medical product manufacturing sites and of local communities.
One of the key project results of the SHiPP is the Sustainable Procurement Index for Health (SPIH), which is a globally established, recognized, and adaptable measurement tool for policymakers, manufacturers, suppliers, procurers, and health care facilities end users. SPIH is designed to provide an incentive for entities to improve their environmental and social sustainability record.
The aim of the Index is to facilitate sustainable procurement in the health sector by supporting the decision making of buyers and certainty for suppliers, to provide a robust and transparent method that communicates supply chain performance and to provide clear pathways for stakeholders to improve their performance.
Without further ado, I would like to hand over to Kristian to describe in more detail how the SPIH is structured, the key themes, questions, and the scoring system and how the SPIH can be deployed in health care organisations.
Thank you very much.
Kristian will deliver
Callum, based on your experience, and work in public health what excites you most about the SPIH?
The SPIH has three main concepts:
It is organised in levels. Level 1 represents baseline performance, and level 3 represents leading performance. Within each level are a set of modules linked to the sustainability themes.
Modules are collections of questions. Each module has been designed with either an organisational or product focus. A module at level 1 has different questions to a module at level 3.
Questions are what the supplier responds to. Most questions are multiple choice, and have a specific weighting within the module. Some questions also require the provision of supporting evidence.
Kristian will deliver
Terry, I’m a potential buyer – not SPHS network - and I’m wondering how I will be able to integrate this into my organisation's procurement processes?
- UN available, non UN method will be Published
Kristian will deliver
Anna, did you feel the piloting exercise was a success and how did it feel seeing the Tool being used?
Kristian just to speak over, before we go to the Q&A